skip to content »

IMBS

Houston, Texas

CMB research is conducted at Baylor College of Medicine in the Texas Medical Center, Houston.
Integrative Molecular and Biomedical Sciences Graduate Program
not shown on screen

Ronald Javier, Ph.D.

Associate Professor, Department of Molecular Virology & Microbiology
Ph.D., University of California, Los Angeles
Postdoctoral, Princeton University

Research Interests:

It has been established that tumorigenic viruses represent powerful tools for revealing molecular mechanisms responsible for the development of human malignancies. In addition to causing acute self-limiting infections in people, certain human adenoviruses are also capable of inducing tumors in rodents. Based on the types of elicited tumors and the oncogenic determinants, two different classes of tumorigenic human adenoviruses can be distinguished. Adenoviruses from subgroups A and B promote undifferentiated sarcomas at the site of inoculation, and the tumorigenic potentials of these viruses depend solely on their E1A and E1B oncoproteins. In contrast, we have shown that human adenovirus type 9 from subgroup D generates exclusively estrogen-dependent mammary tumors and that the tumorigenic potential of this virus depends instead on its E4-ORF1 oncoprotein. My lab is interested in determining the molecular mechanisms underlying tumorigenesis by E4-ORF1. Such knowledge is expected to reveal new insights into how many cancers arise in people.

The results of our studies indicate that the tumorigenic potential of E4-ORF1 is linked to its ability to complex with a select group of cellular PDZ domain-containing proteins, including MUPP1, MAGI-1, ZO-2 and DLG. PDZ domains are 90 amino-acid protein-protein interaction modules found primarily in cellular scaffolding proteins that regulate signal transduction. While the precise functions of the E4-ORF1-associated PDZ proteins are not yet known, these types of polypeptides usually localize membrane receptors and cytosolic proteins to the plasma membrane at specialized regions of cell-cell contact and, at these locations, organize these targets into large signaling complexes. Related to these general activities for PDZ proteins, we have shown that E4-ORF1 selectively and potently activates the phosphoinositide 3-kinase (PI3K) signaling pathway at the plasma membrane of cells. Significantly, this activity is dependent on interactions of E4-ORF1 with its PDZ-protein targets, and is also intimately linked to the ability of E4-ORF1 to transform cultured cells and to promote tumors in animals.

Other findings hint that E4-ORF1-associated PDZ proteins may also be tumor suppressors. With respect to this idea, E4-ORF1 aberrantly sequesters most of its PDZ-protein targets within detergent-insoluble complexes in the cytoplasm of cells. Interestingly, high-risk but not low-risk human papillomavirus (HPV) E6 oncoproteins likewise bind to MUPP1, MAGI-1, and DLG but, in this case, target them for degradation in cells. Additionally, the Tax oncoprotein of human T-cell leukemia virus type 1 also interacts with DLG. These observations suggest that the tumorigenic potentials of several different human virus oncoproteins depend, in part, on their ability to bind and inactivate one or more of the E4-ORF1-associated PDZ proteins in cells.

In light of these findings, the current emphasis of research in my lab is (1) to decipher the novel PDZ-protein dependent mechanism of action whereby E4-ORF1 stimulates the PI3K signaling pathway and (2) to determine whether the E4-ORF1-associated cellular PDZ proteins are tumor suppressors by generating and analyzing mice having these genes disrupted.

Selected Publications:

Chung SH, Weiss RS, Frese KK, Prasad BV, Javier RT. Functionally distinct monomers and trimers produced by a viral oncoprotein. Oncogene. 2007 Sep 10; [Epub ahead of print]

Chung SH, Frese KK, Weiss RS, Prasad BV, Javier RT.A new crucial protein interaction element that targets the adenovirus E4-ORF1oncoprotein to membrane vesicles. J Virol. 2007 May;81(9):4787-97.

Frese KK, Latorre IJ, Chung SH, Caruana G, Bernstein A, Jones SN, Donehower LA, Justice MJ, Garner CC, Javier RT. Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor. EMBO J. 2006 Mar 22;25(6):1406-17.

Latorre IJ, Roh MH, Frese KK, Weiss RS, Margolis B, Javier RT. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells.
J Cell Sci. 2005 Sep 15;118(Pt 18):4283-93.

Latorre IJ, Frese KK, Javier RT. (2004). Tight Junction Proteins and Cancer. In Tight Junctions. Editor, Lorenza Gonzalez-Mariscal. Landes Bioscience, Georgetown, TX.

Frese KK, et al. (2003). Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 22:710-721.

Lee OK, et al.(2003) Discs-Large and Strabismus are functionally linked to plasma membrane formation. Nat Cell Biol. 5:987-93.

Kimber WA, et al. (2002). Evidence that the tandem-pleckstrin-homology-domain-containing protein TAPP1 interacts with Ptd(3,4)P2 and the multi-PDZ-domain-containing protein MUPP1 in vivo. Biochem. J. 361:525-536.

Glaunsinger BA, RS Weiss, SS Lee, Javier RT. (2001). Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. EMBO J. 20:5578-5586.

Thomas D, Schaack J, Vogel H, Javier RT. (2001). Several E4-Region Functions Influence Mammary Tumorigenesis by Human Adenovirus Type 9. J. Virology 75:557-568.

Thomas M, Glaunsinger B, Pim D, Javier RT, Banks L. (2001). HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 20:5431-5439.


For more publications, see listing on PubMed.

Contact Information:

Ronald Javier, Ph.D.
Department of Molecular Virology & Microbiology
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030
(713) 798-3898
Fax: (713) 798-3586
E-mail: rjavier@bcm.edu

Updated: 12/07

E-mail this page to a friend